Finance

Lists
COR:NYSE
Cencora Inc
$ 302.93
-0.29%
(-0.88) 1D
9-р сарын 29, 12:23:50 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COR...
Open
$ 300.00
High
$ 303.90
Low
$ 298.21
Mkt. cap
13.39 тэрбум
Avg. vol.
1.19 сая
Volume
294.67 мян
52-wk high
$ 377.54
52-wk low
$ 244.82
Beta
0.57
Shares outstanding
190.83 сая
No. of employees
49 мян
Open
$ 300.00
High
$ 303.90
Low
$ 298.21
Mkt. cap
13.39 тэрбум
Avg. vol.
1.19 сая
Volume
294.67 мян
52-wk high
$ 377.54
52-wk low
$ 244.82
Beta
0.57
Shares outstanding
190.83 сая
No. of employees
49 мян
News stories
From web sources and news partners
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc
CEORobert Mauch
Employees49 мян
Founded1871
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 12 analysts giving stock ratings to COR in the past 3 months
Strong buy
Buy
9
Hold
3
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for COR in the last 3 months.
Highest
Current $ 302.93
$ 430.00 (+41.95%)
Average
$ 369.18 (+21.87%)
Lowest
$ 330.00 (+8.94%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Halsted
RBC Capital
Hold
Reiterated
$ 330.00
+8.9%
09/04/2026
Glen Santangelo
Barclays
Buy
Reiterated
$ 350.00
+15.5%
08/13/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$ 350.00
+15.5%
08/13/2026
Allen Lutz
Bank of America Securities
Hold
Maintained
$ 330.00
+8.9%
08/12/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
$ 390.00
+28.7%
08/10/2026
Stephen Baxter
Wells Fargo
Buy
Reiterated
$ 395.00
+30.4%
08/11/2026
Charles Rhyee
TD Cowen
Buy
Maintained
$ 400.00
+32%
08/09/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
$ 346.00
+14.2%
08/07/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
$ 370.00
+22.1%
08/06/2026
Kevin Caliendo
UBS
Buy
Maintained
$ 430.00
+41.9%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
$ 370.00
+22.1%
08/06/2026
Ryan Daniels
William Blair
Hold
Reiterated
-
-
08/05/2026
Max Smock
William Blair
Hold
Maintained
-
-
05/22/2026
David Toung
Argus Research
Buy
Reiterated
$ 400.00
+32%
03/17/2026
Last report
2026 оны 8-р сарын 5
Fiscal period
Q3 2026
EPS / Est. (USD)
$ 4.48 / $ 4.35
+3.04%beat
Revenue / Est. (USD)
84.75 тэрбум / 84.15 тэрбум
+0.72%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
83.73 тэрбум
85.93 тэрбум
78.36 тэрбум
84.75 тэрбум
Cost of goods sold
80.78 тэрбум
82.87 тэрбум
74.78 тэрбум
81.15 тэрбум
Cost of revenue
80.78 тэрбум
82.87 тэрбум
74.78 тэрбум
81.15 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.75 тэрбум
1.80 тэрбум
1.98 тэрбум
2.13 тэрбум
Operating expense
2.00 тэрбум
2.06 тэрбум
2.23 тэрбум
2.40 тэрбум
Total operating expenses
82.78 тэрбум
84.93 тэрбум
77.01 тэрбум
83.56 тэрбум
Operating income
944.58 сая
1.00 тэрбум
1.34 тэрбум
1.20 тэрбум
Other non operating income
-49.91 сая
10.10 сая
-173.00 мян
16.88 сая
EBT including unusual items
-187.04 сая
708.64 сая
2.09 тэрбум
996.39 сая
EBT excluding unusual items
795.23 сая
941.56 сая
1.20 тэрбум
1.08 тэрбум
Income tax expense
146.03 сая
142.51 сая
459.04 сая
219.73 сая
Effective tax rate
-78.07%
20.11%
21.98%
22.05%
Other operating expenses
-4.00 сая
362.00 мян
595.00 мян
881.00 мян
Net income
-339.70 сая
559.65 сая
1.64 тэрбум
763.52 сая
Net profit margin
-0.41%
0.65%
2.09%
0.90%
Earnings per share
3.84
4.08
4.75
4.48
Interest and investment income
31.52 сая
20.95 сая
13.88 сая
13.82 сая
Interest expense
-109.36 сая
-93.36 сая
-154.34 сая
-154.52 сая
Net interest expenses
-77.83 сая
-72.41 сая
-140.46 сая
-140.70 сая
Depreciation and amortization charges
131.49 сая
134.29 сая
132.14 сая
150.96 сая
EBITDA
1.21 тэрбум
1.27 тэрбум
1.60 тэрбум
1.47 тэрбум
Gain or loss from assets sale
-
-35.82 сая
-234.00 мян
-15.96 сая
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс